Anti-ERBB2-Phor18 molecules ADC

  • 1.00 Dollar US$
  • Published date: November 30, 2017
  • Modified date: November 30, 2017
    • Shirley, New York, United States

https://www.creative-biolabs.com/adc/target-erbb2-37.htm This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a Phor18 molecules linker to drug.

Result 0 votes
Bella
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-ER-a36 (clone SNGmBI)-MB-VC-duocarmycin ADC

    Anti-ER-a36 (clone SNGmBI)-MB-VC-duocarmycin ADC

    Drug Development Shirley (New York) November 30, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-er-a36-36.htm This ADC product is comprised of an anti-ER-a36 monoclonal antibody (clone SNGmB) conjugated via a MB-VC linker to duocarmycin. The duocarmycin is targeted to certain cancers by immunerecognit...

  • Anti-ER-a36 (clone SNGmBI)-SPDB-DM4 ADC

    Anti-ER-a36 (clone SNGmBI)-SPDB-DM4 ADC

    Drug Development Shirley (New York) November 30, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-er-a36-36.htm This ADC product is comprised of an anti-ER-a36 monoclonal antibody (clone SNGmB) conjugated via a SPDB linker to DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered...

  • Anti-ER-a36 (clone SNGmBI)-SMCC-DM1 ADC

    Anti-ER-a36 (clone SNGmBI)-SMCC-DM1 ADC

    Drug Development Shirley (New York) November 30, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-er-a36-36.htm This ADC product is comprised of an anti-ER-a36 monoclonal antibody (clone SNGmB) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered...